Published in Int Urogynecol J on July 13, 2015
An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction. Neurourol Urodyn (2010) 5.48
Diagnosis and treatment of overactive bladder (non-neurogenic) in adults: AUA/SUFU guideline. J Urol (2012) 2.96
Persistence of therapeutic effect after repeated injections of botulinum toxin type A to treat incontinence due to neurogenic detrusor overactivity. Urology (2006) 1.87
Refractory idiopathic urge urinary incontinence and botulinum A injection. J Urol (2008) 1.85
Single-institution experience in 110 patients with botulinum toxin A injection into bladder or urethra. Urology (2005) 1.77
Botulinum toxin A in the overactive bladder: current status and future directions. BJU Int (2007) 1.69
Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre. Eur Urol (2007) 1.57
Do repeat intradetrusor botulinum toxin type a injections yield valuable results? Clinical and urodynamic results after five injections in patients with neurogenic detrusor overactivity. Eur Urol (2007) 1.53
Defining overactive bladder: epidemiology and burden of disease. Urology (2004) 1.47
What is the optimum dose of type A botulinum toxin for treating neurogenic bladder overactivity? BJU Int (2006) 1.43
Success of repeat detrusor injections of botulinum a toxin in patients with severe neurogenic detrusor overactivity and incontinence. Eur Urol (2005) 1.25
EAU guidelines on assessment and nonsurgical management of urinary incontinence. Eur Urol (2012) 1.23
Botulinum toxin injections for adults with overactive bladder syndrome. Cochrane Database Syst Rev (2011) 1.09
Botulinum toxin for the treatment of idiopathic and neurogenic overactive bladder: state of the art. Rev Urol (2006) 0.90
Relation of postvoid residual to urinary tract infection during stroke rehabilitation. Arch Phys Med Rehabil (2003) 0.86
Anticholinergic drugs versus other medications for overactive bladder syndrome in adults. Cochrane Database Syst Rev (2007) 0.84
Trends in the aetiology of urogenital fistula: a case of 'retrogressive evolution'? Int Urogynecol J (2016) 1.11
The "learning curve" for retropubic mid-urethral sling procedures: a retrospective cohort study. Int Urogynecol J (2015) 0.86
Understanding variations in patient screening and recruitment in a multicentre pilot randomised controlled trial: a vignette-based study. Trials (2016) 0.75
Targeting Deficiencies in the TLR5 Mediated Vaginal Response to Treat Female Recurrent Urinary Tract Infection. Sci Rep (2017) 0.75